Showing results (281-290 of 439) with videos related to

Sort By:
Pageof 44
European Urology|April 3, 2017
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas DatasetWoonyoung Choi, Andrea Ochoa, David J McConkey, et al.
Molecular Genetics and Metabolism|January 18, 2006
Mutation and biochemical analysis of patients belonging to the cblB complementation class of vitamin B12-dependent methylmalonic aciduriaJordan P Lerner-Ellis, Abigail B Gradinger, David Watkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohortSalahaldin A Tahir, Anna Frolov, Teresa G Hayes, et al.
Nature|December 4, 2014
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistanceAntonina V Kurtova, Jing Xiao, Qianxing Mo, et al.
Neurology. Education|August 14, 2025
Education Research: High-Fidelity Simulation to Evaluate Diagnostic Reasoning Reveals Failure to Detect Viral Encephalitis in Medical TraineesMelissa B Pergakis, Wan-Tsu W Chang, Camilo A Gutierrez, et al.
Urology|September 19, 2006
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomyShahrokh F Shariat, Ganesh S Palapattu, Gilad E Amiel, et al.
Urology|March 1, 2008
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomyAmit Gupta, Yair Lotan, Patrick J Bastian, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2010
Evaluation of second-generation sequencing of 19 dilated cardiomyopathy genes for clinical applicationsSivakumar Gowrisankar, Jordan P Lerner-Ellis, Stephanie Cox, et al.
Molecular Neurodegeneration|April 6, 2012
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's diseaseMiriam A Hickey, Chunni Zhu, Vera Medvedeva, et al.
European Urology|October 3, 2006
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomyShahrokh F Shariat, Ganesh S Palapattu, Pierre I Karakiewicz, et al.
Pageof 44